Opinion
21-cv-11096 (LJL)
05-03-2022
(RC) 2 PHARMA CONNECT, LLC, Plaintiff, v. MISSION PHARMACAL COMPANY, Defendant.
ORDER
LEWIS J. LIMAN, UNITED STATES DISTRICT JUDGE
The Court is in receipt of the parties' letters at Dkt. Nos. 67-69 addressing Plaintiff (RC) 2's proposed redactions to Exhibit C to the declaration of Jason Raff, Dkt. No. 62-3, as well as the documents that are subject to (RC) 2's other pending motions to seal.
The limited sealing requests outlined in Dkt. No. 69 are GRANTED, with specific exceptions in Dkt. Nos. 28-5; 28-7; and 28-9; those exceptions are specified in the attached pages. Dkt. No. 8-5, as to which the parties did not provide proposed redactions, should be redacted only to conform with Dkt. No. 28-8.
The parties are directed to ensure that all the documents as to which the motions to seal have been withdrawn and any documents as to which motions to seal were previously filed but which are not addressed in Dkt. No. 69 are filed in full on the public docket and that all the documents addressed in this Order are filed on the public docket with only the limited redactions approved herein by May 10, 2022.
The Clerk of Court is respectfully directed to close the pending sealing motions at Dkt. Nos. 6, 26.
SO ORDERED.